A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients

Investigational New Drugs ◽

10.1007/s10637-006-9019-2 ◽

2006 ◽

Vol 25 (2) ◽

pp. 139-146 ◽

Author(s):

Thomas W. Flaig ◽

Daniel L. Gustafson ◽

Lih-Jen Su ◽

Joseph A. Zirrolli ◽

Frances Crighton ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Cancer Patients ◽

Pharmacokinetic Study

Download Full-text

704 POSTER A phase I dose escalation and pharmacokinetic study of BIBF 1120, a novel tyrosine kinase inhibitor against VEGFR, PDGFR and FGFR, in combination with docetaxel in advanced chemonaive hormone refractory prostate cancer patients (HRPC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70503-7 ◽

2007 ◽

Vol 5 (4) ◽

pp. 108 ◽

Author(s):

E. Raymond ◽

F. Goldwasser ◽

G. Bousquet ◽

C. Le Tourneau ◽

S. Faivre ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Pharmacokinetic Study ◽

Dose Escalation ◽

Kinase Inhibitor ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Download Full-text

A phase I and pharmacokinetic study of irinotecan given as a 7 days continuous infusion in metastatic colorectal cancer patients pretreated with 5-FU or raltitrexed

European Journal of Cancer ◽

10.1016/s0959-8049(01)81579-3 ◽

2001 ◽

Vol 37 ◽

pp. S294-S295

Author(s):

G. Masi ◽

A. Di Paolo ◽

G. Allegrini ◽

S. Cupini ◽

C. Galli ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Continuous Infusion ◽

Cancer Patients ◽

Pharmacokinetic Study ◽

Colorectal Cancer Patients

Download Full-text

Cross-trial Analysis of Immunologic and Clinical Data Resulting From Phase I and II Trials of MVA-5T4 (TroVax) in Colorectal, Renal, and Prostate Cancer Patients

Journal of Immunotherapy ◽

10.1097/cji.0b013e3181f5dac7 ◽

2010 ◽

Vol 33 (9) ◽

pp. 999-1005 ◽

Author(s):

Richard Harrop ◽

William Shingler ◽

Michelle Kelleher ◽

Jackie de Belin ◽

Peter Treasure

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Cancer Patients ◽

Clinical Data ◽

Trial Analysis ◽

Download Full-text

Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients

European Journal of Cancer ◽

10.1016/s0959-8049(05)80206-0 ◽

1993 ◽

Vol 29 (7) ◽

pp. 983-988 ◽

Author(s):

M. de Forni ◽

J.-P. Armand ◽

X. Fontana ◽

G. Recondo ◽

C. Domenge ◽

...

Keyword(s):

Phase I ◽

Cancer Patients ◽

Pharmacokinetic Study

Download Full-text

A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients

Acta Oncologica ◽

10.1080/0284186x.2021.1979246 ◽

2021 ◽

pp. 1-6

Author(s):

Stine E. Petersen ◽

Lise B. Thorsen ◽

Steinbjørn Hansen ◽

Peter M. Petersen ◽

Henriette Lindberg ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Pelvic Radiation ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study

The Prostate ◽

10.1002/pros.21362 ◽

2011 ◽

Vol 71 (13) ◽

pp. 1455-1465 ◽

Author(s):

Jayaprakash Karkera ◽

Hannes Steiner ◽

Weimin Li ◽

Viktor Skradski ◽

Patrizia L. Moser ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Cancer Patients ◽

Interleukin 6 ◽

Download Full-text

A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions

European Journal of Cancer ◽

10.1016/j.ejca.2010.02.002 ◽

2010 ◽

Vol 46 (8) ◽

pp. 1474-1480 ◽

Author(s):

Xianhuo Wang ◽

Junchao Zhou ◽

Yongsheng Wang ◽

Zhengyan Zhu ◽

You Lu ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Pharmacokinetic Study ◽

Pleural Effusions ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Paclitaxel Liposome

Download Full-text

A Phase I and Pharmacokinetic Study of Irinotecan Given as a 7-Day Continuous Infusion in Metastatic Colorectal Cancer Patients Pretreated with 5-Fluorouracil or Raltitrexed

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-1585-3 ◽

2004 ◽

Vol 10 (5) ◽

pp. 1657-1663 ◽

Author(s):

Gianluca Masi ◽

Alfredo Falcone ◽

Antonello Di Paolo ◽

Giacomo Allegrini ◽

Romano Danesi ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Continuous Infusion ◽

Cancer Patients ◽

Pharmacokinetic Study ◽

Colorectal Cancer Patients

Download Full-text

Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

Cytotherapy ◽

10.1016/j.jcyt.2017.02.025 ◽

2017 ◽

Vol 19 (5) ◽

pp. S15 ◽

Author(s):

A.A. Tryggestad ◽

I. Bigalke ◽

K. Axcrona ◽

E. Inderberg ◽

G. Skorstad ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

A26. A phase I/II pilot trial of low-dose, sustained-release GTN for prostate cancer patients with recurrence after primary therapy

Nitric Oxide ◽

10.1016/j.niox.2007.09.031 ◽

2007 ◽

Vol 17 ◽

pp. 15 ◽

Author(s):

D.R. Siemens ◽

J. Heaton ◽

M. Adams ◽

C. Graham

Keyword(s):

Prostate Cancer ◽

Sustained Release ◽

Phase I ◽

Cancer Patients ◽

Low Dose ◽

Pilot Trial ◽

Primary Therapy

Download Full-text